Choi SY - Search Results

1

Epithelial immune cell-like transition (EIT): a proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancers.

Choi SY, Gout PW, Collins CC, Wang Y. Choi SY, et al. Differentiation. 2012 Jun;83(5):293-8. doi: 10.1016/j.diff.2012.02.005. Epub 2012 Apr 1. Differentiation. 2012. PMID: 22472059 Review.

2

Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?

Choi SY, Collins CC, Gout PW, Wang Y. Choi SY, et al. J Pathol. 2013 Aug;230(4):350-5. doi: 10.1002/path.4218. J Pathol. 2013. PMID: 23729358 Free PMC article. Review.

3

Lessons from patient-derived xenografts for better in vitro modeling of human cancer.

Choi SY, Lin D, Gout PW, Collins CC, Xu Y, Wang Y. Choi SY, et al. Adv Drug Deliv Rev. 2014 Dec 15;79-80:222-37. doi: 10.1016/j.addr.2014.09.009. Epub 2014 Oct 13. Adv Drug Deliv Rev. 2014. PMID: 25305336 Free article. Review.

4

The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer.

Choi SY, Xue H, Wu R, Fazli L, Lin D, Collins CC, Gleave ME, Gout PW, Wang Y. Choi SY, et al. Clin Cancer Res. 2016 Jun 1;22(11):2721-33. doi: 10.1158/1078-0432.CCR-15-1624. Epub 2016 Jan 11. Clin Cancer Res. 2016. PMID: 26755530

5

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.

Lin D, Ettinger SL, Qu S, Xue H, Nabavi N, Choi SYC, Bell RH, Mo F, Haegert AM, Gout PW, Fleshner N, Gleave ME, Pollak M, Collins CC, Wang Y. Lin D, et al. Oncotarget. 2017 Apr 18;8(16):25928-25941. doi: 10.18632/oncotarget.15237. Oncotarget. 2017. PMID: 28460430 Free PMC article.

6

Immune phenotypes of prostate cancer cells: Evidence of epithelial immune cell-like transition?

Lin D, Wang X, Choi SYC, Ci X, Dong X, Wang Y. Lin D, et al. Asian J Urol. 2016 Oct;3(4):195-202. doi: 10.1016/j.ajur.2016.08.002. Epub 2016 Aug 20. Asian J Urol. 2016. PMID: 29264187 Free PMC article. Review.

7

Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.

Hao J, Ci X, Xue H, Wu R, Dong X, Choi SYC, He H, Wang Y, Zhang F, Qu S, Zhang F, Haegert AM, Gout PW, Zoubeidi A, Collins C, Gleave ME, Lin D, Wang Y. Hao J, et al. Eur Urol. 2018 Jun;73(6):949-960. doi: 10.1016/j.eururo.2018.02.019. Epub 2018 Mar 12. Eur Urol. 2018. PMID: 29544736 Free article.

8

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.

Choi SYC, Ettinger SL, Lin D, Xue H, Ci X, Nabavi N, Bell RH, Mo F, Gout PW, Fleshner NE, Gleave ME, Collins CC, Wang Y. Choi SYC, et al. Cancer Med. 2018 Jul;7(7):3385-3392. doi: 10.1002/cam4.1587. Epub 2018 Jun 14. Cancer Med. 2018. PMID: 29905005 Free PMC article.

9

Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells.

Wong J, Choi SYC, Liu R, Xu E, Killam J, Gout PW, Wang Y. Wong J, et al. Front Cell Infect Microbiol. 2019 Feb 12;9:25. doi: 10.3389/fcimb.2019.00025. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 30809511 Free PMC article.

10

Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development.

Ci X, Hao J, Dong X, Xue H, Wu R, Choi SYC, Haegert AM, Collins CC, Liu X, Lin D, Wang Y. Ci X, et al. Cells. 2020 Jun 4;9(6):1398. doi: 10.3390/cells9061398. Cells. 2020. PMID: 32512818 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,258 results

Search Page